Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 3
2005 1
2006 1
2008 1
2009 2
2013 1
2014 1
2016 2
2017 3
2018 1
2019 3
2020 1
2021 2
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Response to anti-SARS-CoV-2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients.
Zaleska J, Kwasnik P, Paziewska M, Purkot J, Szabelak A, Jurek M, Masny N, Dziatkiewicz I, Pronobis-Szczylik B, Piebiak A, Szymczyk A, Jarosz-Chudzik K, Bolkun L, Kozlowska K, Piszcz J, Subocz E, Halka J, Bator M, Kalicinska E, Wrobel T, Usnarska-Zubkiewicz L, Rybka J, Deren-Wagemann I, Szyca-Smieszniak M, Dybko J, Hus I, Pula B, Cichocka E, Rymko M, Zdunczyk D, Ziarkiewicz M, Basak GW, Bullinger L, Giannopoulos K. Zaleska J, et al. Among authors: kozlowska k. Int J Cancer. 2023 Feb 15;152(4):705-712. doi: 10.1002/ijc.34209. Epub 2022 Jul 27. Int J Cancer. 2023. PMID: 35830214 Free PMC article.
Global Increase in Circular RNA Levels in Myotonic Dystrophy.
Czubak K, Taylor K, Piasecka A, Sobczak K, Kozlowska K, Philips A, Sedehizadeh S, Brook JD, Wojciechowska M, Kozlowski P. Czubak K, et al. Among authors: kozlowska k. Front Genet. 2019 Jul 18;10:649. doi: 10.3389/fgene.2019.00649. eCollection 2019. Front Genet. 2019. PMID: 31428124 Free PMC article.
Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model.
Siemionow M, Brodowska S, Langa P, Zalants K, Kozlowska K, Grau-Kazmierczak W, Heydemann A. Siemionow M, et al. Among authors: kozlowska k. Arch Immunol Ther Exp (Warsz). 2022 Aug 17;70(1):20. doi: 10.1007/s00005-022-00656-7. Arch Immunol Ther Exp (Warsz). 2022. PMID: 35978142 Free PMC article.
Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M, Langa P, Brodowska S, Kozlowska K, Zalants K, Budzynska K, Heydemann A. Siemionow M, et al. Among authors: kozlowska k. Stem Cell Rev Rep. 2022 Dec;18(8):2872-2892. doi: 10.1007/s12015-022-10384-2. Epub 2022 May 19. Stem Cell Rev Rep. 2022. PMID: 35590083 Free PMC article.
Correction: Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M, Langa P, Brodowska S, Kozlowska K, Zalants K, Budzynska K, Heydemann A. Siemionow M, et al. Among authors: kozlowska k. Stem Cell Rev Rep. 2023 Feb;19(2):582-583. doi: 10.1007/s12015-022-10472-3. Stem Cell Rev Rep. 2023. PMID: 36441490 Free PMC article. No abstract available.
29 results